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Abstract
Introduction:  Intestinal  angioedema  is  a  rare  adverse  effect  of  angiotensin  converting  enzyme
inhibitors.
Clinical case:  A  42-year  old  woman  presented  to  the  Emergency  Department  complaining  of
diffuse abdominal  pain,  predominantly  in  the  right  quadrants,  with  no  other  associated  symp-
toms.
She had  been  started  on  perindopril  plus  indapamide  72  h  before  the  admission  for  arterial
hypertension.  There  was  no  other  relevant  background.
Physical  examination  suggested  peritoneal  irritation  on  the  lower  quadrants  of  the  abdomen
and right  ﬂank.
Laboratory  tests  were  relevant  for  mild  leukocytosis.  Abdomen  ultrasound  and  contrast-
enhanced  computed  tomography  scan  showed  moderate  amount  of  ﬂuid  in  the  pelvic  excavation
and small  intestine  wall  thickening.  She  was  admitted  for  observation.  Once  the  hypothesis  of
intestinal angioedema  was  admitted,  angiotensin  converting  enzyme  inhibitor  was  withheld  and
no other-directed  therapy  was  instituted.  Within  24  h  she  showed  clinical,  analytic  and  imaging
improvement,  thus  supporting  this  diagnosis.
Conclusion:  The  diagnosis  of  intestinal  angioedema  induced  by  angiotensin  converting  enzyme
inhibitor  can  be  challenging  and  time  consuming  due  to  its  rarity  and  nonspeciﬁc  symptoms,
which may  lead  to  underdiagnosis  of  this  entity.
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Angioedema  Visceral  Induzido  por  Inibidor  da  Enzima  de  Conversão  da  Angiotensina:
Caso  Clínico
Resumo
Introduc¸ão:  O  angioedema  intestinal  é  um  efeito  adverso  raro  dos  inibidores  da  enzima  de
conversão  da  angiotensina.
Caso  clínico:  Sexo  feminino,  42  anos,  recorreu  ao  Servic¸o  de  Urgência  por  dor  abdominal  difusa
predominante  nos  quadrantes  direitos,  sem  outra  sintomatologia.  Tinha  iniciado  perindopril
e indapamida  72  horas  antes  por  hipertensão  arterial.  Sem  outros  antecedentes  de  relevo.
Ao exame  objetivo  salientava-se  apenas  sinais  de  irritac¸ão  peritoneal  à  palpac¸ão  da  fossa
ilíaca e  ﬂanco  direitos.  Analiticamente  evidenciava  discreta  leucocitose,  sem  outras  alterac¸ões.
A ecograﬁa  e  tomograﬁa  computorizada  contrastada  abdominal  revelaram  líquido  moderado
na escavac¸ão  pélvica  e  espessamento  das  paredes  do  delgado.  Foi  internada  para  vigilância.
Admitindo-se  angioedema  intestinal,  o  inibidor  da  enzima  de  conversão  da  angiotensina  foi  sus-
penso e  não  foi  instituída  qualquer  outra  terapêutica  dirigida.  Em  24  horas,  veriﬁcou-se  melhoria
clínica,  analítica  e  imagiológica,  corroborando  a  hipótese  de  diagnóstico.
Conclusão:  O  diagnóstico  de  angioedema  intestinal  por  inibidor  da  enzima  de  conversão  da
angiotensina  é,  por  vezes,  difícil  e  moroso  pela  sua  raridade  e  inespeciﬁcidade  dos  sintomas,
podendo conduzir  ao  subdiagnóstico  desta  entidade.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.
Este é  um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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s1. Introduction
Angiotensin  converting  enzyme  (ACE)  inhibitors  are  widely
used  in  clinical  practice.  Angioedema  is  a  rare  adverse
reaction,  occurring  in  approximately  0.1--0.7%  of  patients.1
Although  the  risk  to  an  individual  is  relatively  low,  the  large
number  of  people  taking  these  medications,  calculated  in
more  than  40  million  patients  in  the  United  States,  means
the  absolute  number  of  ACE  inhibitor  induced  angioedema
is,  in  fact,  signiﬁcant.1 Most  of  the  cases  described  in  lit-
erature  refer  to  angioedema  of  the  lips,  tongue,  face,  or
airway.1 More  rarely,  visceral  involvement  may  occur,  espe-
cially  in  the  jejunum.1--3 The  exact  incidence  of  visceral
angioedema  induced  by  ACE  inhibitor  is  unknown  and  this
condition  is  probably  underdiagnosed.1,4--7 In  a  literature
review  from  1980  to  2010,  Korniyenko  et  al  reported  27
published  cases.3
The  authors  present  a  case  of  intestinal  angioedema
induced  by  ACE  inhibitor.
2. Clinical case
A  42-year  old  caucasian  woman  presented  to  the  Emergency
Department  complaining  of  diffuse  abdominal  pain,  predom-
inantly  in  the  right  quadrants,  for  the  last  10  h.  She  was
previously  asymptomatic  and,  at  admission,  did  not  have
any  other  symptoms,  including  nausea,  vomiting,  diarrhea
or  any  other  gastrointestinal  symptom,  breathing  difﬁculty,
cough,  rash  or  pruritus.
She  had  been  started  on  perindopril  plus  indapamide  72  h
before  the  admission  for  arterial  hypertension,  with  no  other
relevant  background.
At  admission,  signiﬁcant  ﬁndings  on  physical  exam
included  an  arterial  pressure  of  112/72  mmHg,  pulse  of
s
a
t1  per  minute,  peripheral  oxygen  saturation  of  100%  on
oom  air  and  tympanic  temperature  of  37 ◦C.  There  was
o  swelling  of  the  face,  oral  cavity  or  tongue,  dyspnea  or
tridor.  Abdominal  examination  showed  signs  of  peritoneal
rritation  on  lower  quadrants  of  the  abdomen  and  right
ank.
Laboratory  tests  were  relevant  for  mild  leukocytosis  with
igh  neutrophil  count  (12.910  leukocyte/L, 79.2%  of  neu-
rophil).  The  remaining  analysis,  including  liver  enzymes
ere  within  the  normal  range  --  aminotransferase  aspar-
ate:  22  U/L,  aminotransferase  alanine:  22  U/L  (normal
--33/4--50,  respectively),  pancreatic  amylase:  28  U/L  (nor-
al  13--53),  lipase:  24  U/L  (normal  13--60)  or  C-reactive
rotein:  0.35  mg/dL  (normal  <0.5).  Abdominal  ultrasound
evealed  thickening  of  intestinal  wall  associated  with
bdominal  ﬂuid.  A  contrast-enhanced  abdominal  computed
omography  (CT)  was  done  for  further  characterization
Fig.  1),  showing  a  moderate  amount  of  liquid  in  the  pelvic
xcavation  and  wall  thickening  of  small  intestine,  cecum  and
scending  colon.
She  was  admitted  for  observation.  Once  the  hypothe-
is  of  intestinal  angioedema  was  admitted,  ACE  inhibitor
as  withheld.  The  patient  was  started  on  intravenous  ﬂuids
nd  analgesics  and  kept  on  nothing  by  mouth  status.  Within
4  h  she  showed  clinical,  analytic  and  imaging  improve-
ent,  with  ultrasound  still  revealing  moderate  free  ﬂuid,
ut  less  expressive  wall  thickening  of  the  small  intestine
oops.
The  clear  improvement  in  24  h  without  other  treat-
ent  besides  perindopril  withholding,  in  the  scenario  of  no
ymptoms  or  history  suggestive  of  any  alternative  diagnosis
trongly  supported  ACE  inhibitor  induced  angioedema.
The  patient  was  discharged  home,  advised  not  to  resume
ny  ACE  inhibitors.  One  year  later  she  remained  asymp-
omatic.
168  
Figure  1  Contrast-enhanced  computed  tomography  demon-
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Rtrating circumferential  transmural  thickening  of  ileum  walls,
roducing  a  target-like  lesion  (arrows)  that  is  typical  of  edema.
. Discussion
isceral  angioedema  induced  by  ACE  inhibitor  is  a  rare,  but
ell-established  entity,  described  in  some  publications.3
Studies  suggest  that  elevated  levels  of  bradykinin,  a
asodilator  peptide  degraded  by  angiotensin  converting
nzyme,  result  in  vasodilation  and  increased  vascular  per-
eability  causing  the  edema.1,3,4,8,9
Female  sex  appears  to  have  a  major  predisposition  to  it
nd  its  incidence  is  ﬁve  times  greater  in  black  people.1,4,10
Jejunum  is  most  often  affected  followed  by  ileum  and
uodenum.1--3 There  are  reports  of  gastric  involvement.3,11
ACE  inhibitor  induced  angioedema  is  characterized  by  the
bsence  of  pruriginous  rash.1,5
It  presents  as  diffuse  abdominal  pain,  diarrhea,  vomi-
ing  and  anorexia.1--3,12 Symptoms  usually  begin  72  h after
tarting  ACE  inhibitor,8,13--15 but  there  are  reports  of
ngioedema  that  developed  after  weeks10,16 or  years  of
herapy.2,10,17,18 Typically  symptoms  resolve  48  h  after  ACE
nhibitor  suspension.3,4
The  laboratory  evaluation  is  often  normal  or  it  may
xhibit  mild  leukocytosis.2,3
Radiologic  studies  show  small  intestine  wall  thicken-
ng,  mesenteric  edema  and  ascites2,3,7,10,13,19--22 that  may
imulate  ischemia  or  inﬂammatory  bowel  disease.2,4,19,21,22
ypically,  there  are  target-like  images  on  contrast-enhanced
adiologic  studies  speciﬁc  of  intestinal  wall  edema,  no  mat-
er  the  cause  of  the  edema.2,3,19,22
Oudit  et  al,4 proposed  four  diagnostic  criteria  based  on
he  use  of  ACE  inhibitor  (regardless  of  dose  and  duration  of
se),  nonspeciﬁc  abdominal  complaints  in  the  presence  of
isceral  edema  (with  or  without  ascites),  resolution  of  symp-
oms  and  radiological  changes  following  discontinuation  of
CE  inhibitor  and  lack  of  alternative  diagnoses.
In  this  report,  opposite  to  other  publications,  the  only
omplain  was  abdominal  pain,  with  no  additional  gastroin-
estinal  symptoms.  However,  presentation  within  72  h  after
tarting  perindopril,  unspeciﬁc  laboratory  ﬁndings,  as  well
s  characteristic  imaging  were  suggestive  and  facilitated
he  diagnosis  of  ACE  inhibitor  angioedema.  Furthermore,
s  there  is  not  a  single,  deﬁnitive  diagnostic  test  it  is  cru-
ial  to  rule  out  other  possible  diagnoses.  In  this  case,  theB.  Frutuoso  et  al.
linical  history  and  complementary  methods  of  diagnosis
llowed  the  exclusion  of  acute  hepatitis  or  pancreatitis,
esenteric  ischemia,  intestinal  obstruction,  appendicitis,
cute  cholecystitis  or  lymphoproliferative  disease.  Acute
astroenteritis  was  very  unlikely,  given  the  lack  of  other
ymptoms  beyond  abdominal  pain.  There  was  no  personal
r  family  history  that  led  into  the  hypothesis  of  hereditary
1  esterase  inhibitor  deﬁciency,  vasculitis  or  inﬂamma-
ory  bowel  disease.  Global  improvement  after  suspension
f  the  drug,  with  no  other-directed  therapy,  supported  this
ypothesis.
. Conclusion
isceral  angioedema  is  a  rare,  but  well-described  adverse
ffect  of  ACE  inhibitor  therapy.  The  diagnosis  is  often  chal-
enging  and  time  consuming,  requiring  careful  evaluation  of
he  patient’s  medication  and  their  side  effects.
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